NeoCore Technology Co., Ltd. (TPEX:4131)
37.25
-0.45 (-1.19%)
Mar 4, 2026, 1:33 PM CST
NeoCore Technology Market Cap
NeoCore Technology has a market cap or net worth of 1.49 billion as of March 3, 2026. Its market cap has increased by 17.81% in one year.
Market Cap
1.49B
Enterprise Value
1.54B
Revenue
190.10M
Ranking
n/a
PE Ratio
n/a
Stock Price
37.25
Market Cap Chart
Since November 3, 2004, NeoCore Technology's market cap has increased from 15.79M to 1.49B, an increase of 9,328.01%. That is a compound annual growth rate of 23.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 1.49B | -10.24% |
| Dec 31, 2025 | 1.66B | 31.25% |
| Dec 31, 2024 | 1.26B | 45.45% |
| Dec 29, 2023 | 869.00M | 123.11% |
| Dec 26, 2022 | 389.50M | 24.09% |
| Dec 28, 2021 | 313.90M | 1.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TaiRx | 2.10B |
| Chunghwa Chemical Synthesis & Biotech | 2.08B |
| Advagene Biopharma | 1.97B |
| Genomics BioSci & Tech. | 1.81B |
| Abnova (Taiwan) | 1.53B |
| GenMont Biotech Incorporation | 1.53B |
| Great Novel Therapeutics Biotech & Medicals | 1.46B |
| Enimmune | 1.36B |